The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kemp Dolliver's Stock Ratings
Brookline Capital Analyst
Kemp Dolliver is an analyst at Brookline Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/14/2025
Overall Average Return
-28.0%
Smart Score
Overall Average Return Percentile
8th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/05/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.71 | 260.93% | Kemp Dolliver27% | → $17 | Initiates | → Buy | Get Alert |
| 11/15/2024 | EYEN | Buy Now | Eyenovia | $2.41 | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 10/02/2024 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 09/12/2024 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 07/22/2024 | IBIO | Buy Now | iBio | $0.96 | 275% | Kemp Dolliver27% | → $3.6 | Initiates | → Buy | Get Alert |
| 05/15/2024 | DARE | Buy Now | Dare Bioscience | $3.00 | -0.04% | Kemp Dolliver27% | → $3 | Upgrade | Hold → Buy | Get Alert |
| 04/17/2024 | DARE | Buy Now | Dare Bioscience | $3.00 | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 01/25/2024 | OTLK | Buy Now | Outlook Therapeutics | $1.85 | -15.14% | Kemp Dolliver27% | → $1.57 | Upgrade | Hold → Buy | Get Alert |
| 12/21/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | Kemp Dolliver27% | $27 → $12.5 | Downgrade | Buy → Hold | Get Alert |
| 12/19/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.39 | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 12/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Kemp Dolliver27% | → $2 | Upgrade | Hold → Buy | Get Alert |
| 11/30/2023 | LNTH | Buy Now | Lantheus Holdings | $77.83 | 28.49% | Kemp Dolliver27% | → $100 | Initiates | → Buy | Get Alert |
| 10/17/2023 | EYEN | Buy Now | Eyenovia | $2.41 | 231.95% | Kemp Dolliver27% | → $8 | Initiates | → Buy | Get Alert |
| 10/12/2023 | EDSA | Buy Now | Edesa Biotech | $2.05 | 2680.49% | Kemp Dolliver27% | → $57 | Maintains | Buy | Get Alert |
| 09/06/2023 | PROC | Buy Now | Procaps Gr | — | — | Kemp Dolliver27% | → $4.5 | Downgrade | Buy → Hold | Get Alert |
| 05/18/2023 | GNLX | Buy Now | Genelux | $3.04 | 721.4% | Kemp Dolliver27% | → $25 | Initiates | → Hold | Get Alert |
| 05/01/2023 | NHWK | Buy Now | NightHawk Biosciences | — | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 04/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Kemp Dolliver27% | — | Downgrade | Buy → Hold | Get Alert |
| 01/13/2023 | ECOR | Buy Now | electroCore | $5.75 | -78.26% | Kemp Dolliver27% | → $1.25 | Initiates | → Buy | Get Alert |
| 12/16/2022 | EDSA | Buy Now | Edesa Biotech | $2.05 | 534.15% | Kemp Dolliver27% | → $13 | Maintains | Buy | Get Alert |
| 10/21/2022 | SCYX | Buy Now | SCYNEXIS | $0.88 | 809.71% | Kemp Dolliver27% | → $8 | Assumes | → Buy | Get Alert |
| 03/10/2022 | VRCA | Buy Now | Verrica Pharmaceuticals | $0.65 | 2957.17% | Kemp Dolliver27% | → $20 | Initiates | → Buy | Get Alert |
| 02/02/2022 | ICCM | Buy Now | Icecure Medical | $1.00 | 465.23% | Kemp Dolliver27% | → $5.65 | Initiates | → Buy | Get Alert |
